Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Sumoylated PPARα mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice
Nicolas Leuenberger, Sylvain Pradervand, Walter Wahli
Nicolas Leuenberger, Sylvain Pradervand, Walter Wahli
View: Text | PDF
Research Article Genetics

Sumoylated PPARα mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice

  • Text
  • PDF
Abstract

As most metabolic studies are conducted in male animals, understanding the sex specificity of the underlying molecular pathways has been broadly neglected; for example, whether PPARs elicit sex-dependent responses has not been determined. Here we show that in mice, PPARα has broad female-dependent repressive actions on hepatic genes involved in steroid metabolism and immunity. In male mice, this effect was reproduced by the administration of a synthetic PPARα ligand. Using the steroid oxysterol 7α-hydroxylase cytochrome P450 7b1 (Cyp7b1) gene as a model, we elucidated the molecular mechanism of this sex-specific PPARα-dependent repression. Initial sumoylation of the ligand-binding domain of PPARα triggered the interaction of PPARα with GA-binding protein α (GABPα) bound to the target Cyp7b1 promoter. Histone deacetylase and DNA and histone methylases were then recruited, and the adjacent Sp1-binding site and histones were methylated. These events resulted in loss of Sp1-stimulated expression and thus downregulation of Cyp7b1. Physiologically, this repression conferred on female mice protection against estrogen-induced intrahepatic cholestasis, the most common hepatic disease during pregnancy, suggesting a therapeutic target for prevention of this disease.

Authors

Nicolas Leuenberger, Sylvain Pradervand, Walter Wahli

×

Figure 7

PPARα protects against estrogen-mediated hepatoxicity in females.

Options: View larger image (or click on image) Download as PowerPoint
PPARα protects against estrogen-mediated hepatoxicity in females.
(A and...
(A and B) Female PPARα-null and WT mice treated (black bars) or not treated (white bars) for 5 days with EE2. (C and D) Female PPARα-null and WT mice were treated for 5 days with EE2, with (black bars) or without (white bars) fenofibrate. (A and C) Hepatic Cyp7b1 and C6 mRNA levels were measured by QPCR and normalized to the 36B4 expression level. (B and D) Plasma bilirubin concentration. In A–D, values are presented as mean ± SEM (n = 4). *P ≤ 0.05; **P ≤ 0.01. (E) Schematic representation of the PPARα-induced repression of Cyp7b1 in females. Sumoylation of PPARα promotes interaction with GABPs and HDACs, leading to DNA methylation by Dnmt3 and the displacement of Sp1 from its methylated core binding site. Removal of PPARα in female mice promotes the removal of the repression complex, which leads to Cyp7b1 stimulation. (F) Schematic representation of the protective effect of PPARα against estrogen-mediated inflammation and hepatotoxicity in females (F). αH3-K9 ac, αhistone 3 acetylated at Lys9; αH3-K9 tri-me, αhistone 3 trimethylated at Lys9.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts